Predictors of rapid HIV testing acceptance and successful nevirapine administration in zambian labor wards

Journal of Acquired Immune Deficiency Syndromes

Volumn 52, Issue 2, 2009, Pages 273-279

  Megazzini, Karen M ^a,c,h   Chintu, Namwinga ^c   Vermund, Sten H ^c,d,e   Redden, David T ^a   Krebs, Daniel W ^c   Simwenda, Maureen ^f   Tambatamba, Bushimbwa ^c   Sinkala, Moses ^g   Stringer, Jeffrey S A ^b,c,f  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^d Institute for Global Health   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ZAMBIA   (Zambia)

^g Catholic Medical Mission Board   (Zambia)

^h WESTAT   (United States)

Author keywords

Antiretroviral prophylaxis; HIV; Labor ward; Motherto child transmission; Nevirapine; Sub Saharan Africa

Indexed keywords

CALCIUM; NEVIRAPINE;

ADULT; ARTICLE; CONTROLLED STUDY; COUNSELING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION CONTROL; LABOR; MAJOR CLINICAL STUDY; PRIMIGRAVIDA; PRIORITY JOURNAL; SEROLOGY; UTERINE CERVIX DILATATION; VERTICAL TRANSMISSION; ZAMBIA;

ANTI-HIV AGENTS; CHEMOPREVENTION; CLINICAL LABORATORY TECHNIQUES; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LABOR, OBSTETRIC; MOLECULAR DIAGNOSTIC TECHNIQUES; NEVIRAPINE; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; ZAMBIA;

EID: 70349656902     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181ab6e7c     Document Type: Article

References (24)

1. Kowalczyk J, Jolly P, Karita E, et al. Voluntary counseling and testing for HIV among pregnant women presenting in labor in Kigali, Rwanda. J Acquir Immune Defic Syndr. 2002;31:408-415.
2. Ong'ech JO, Kiarie JN, Mbori-Ngacha D, et al. Improving Effectiveness of a PMCT Program Through a Multi-Pronged Approach in a Large Public Hospital in Nairobi, Kenya. XV International AIDS Conference, Bangkok, Thailand, 11-16 July, 2004. Abstract no. ThPeB7059.
3. Stringer JS, Sinkala M, Maclean CC, et al. Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia. AIDS. 2005;19:1309-1315.
4. Temmerman M, Quaghebeur A, Mwanyumba F, et al. Mother-to-child HIV transmission in resource poor settings: how to improve coverage? AIDS. 2003;17:1239-1242.
5. van't Hoog AH, Mbori-Ngacha DA, Marum LH, et al. Preventing motherto- child transmission of HIV in Western Kenya: operational issues. J Acquir Immune Defic Syndr. 2005;40:344-349.
6. Bulterys M, Jamieson DJ, O'Sullivan MJ, et al. Rapid HIV-1 testing during labor: a multicenter study. JAMA. 2004;292:219-223.
7. Homsy J, Kalamya JN, Obonyo J, et al. Routine intrapartum HIV counseling and testing for prevention of mother-to-child transmission of HIV in a rural Ugandan hospital. JAcquir ImmuneDefic Syndr. 2006;42:149-154.
8. Nogueira SA, Lambert JS, Albuquerque AL, et al. Assessment of a rapid HIV test strategy during labor: a pilot study from Rio de Janeiro, Brazil. J Hum Virol. 2001;4:278-282.
9. Sagay AS, Musa J, Adewole AS, et al. Rapid HIV testing and counselling in labour in a northern Nigerian setting. Afr J Reprod Health. 2006; 10:76-80.
10. Celentano DD. Is HIV screening in the labor and delivery unit feasible and acceptable in low-income settings? PLoS Med. 2008;5:e107.
11. Pai NP, Barick R, Tulsky JP, et al. Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India. PLoS Med. 2008;5:e92.
12. Stringer JS, Sinkala M, Goldenberg R, et al. Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1. Lancet. 2003;362:667.
13. Reithinger R, Megazzini K, Durako SJ, et al. Monitoring and evaluation of programmes to prevent mother to child transmission of HIV in Africa. BMJ. 2007;334:1143-1146.
14. Stringer EM, Chi BH, Chintu N, et al. Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lowerincome countries. Bull World Health Organ. 2008;86:57-62.
15. Megazzini KM, Sinkala M, Vermund SH, et al. A Cluster-Randomized Trial of Enhanced Labor Ward-Based PMTCT Services to Increase Population Nevirapine Coverage in Lusaka, Zambia. XVII International AIDS Conference, Mexico City, Mexico, 3-8 August, 2008. Abstract no. THAC0405.
16. Mirochnick M, Dorenbaum A, Blanchard S, et al. Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose. J Acquir Immune Defic Syndr. 2003;33:153-156.
17. Stringer JS, Sinkala M, Chapman V, et al. Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine. AIDS. 2003;17:1659-1665.
18. Manzi M, Zachariah R, Teck R, et al. High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. Trop Med Int Health. 2005;10:1242-1250.
19. Taha TE, Kumwenda NI, Hoover DR, et al. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA. 2004;292:202-209.
20. Jamieson DJ, Cohen MH, Maupin R, et al. Rapid human immunodefi- ciency virus-1 testing on labor and delivery in 17 US hospitals: the MIRIAD experience. Am J Obstet Gynecol. 2007;197:S72-S82.
21. CDC. HIV testing among pregnant women-United States and Canada, 1998-2001. MMWR Morb Mortal Wkly Rep. 2002;51:1013-1016.
22. UNAIDS/WHO. Policy Statement on HIV Testing. 2004.
23. CDC. Advancing HIV prevention: new strategies for a changing epidemic- United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:329-332
24. CDC. Rapid HIVantibody testing during labor and delivery for women of unknown HIV status: a practical guide and model protocol, 2004. Atlanta, GA: CDC, National Center for HIV, STD, and TB Prevention; 2004.